Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Capital Expenditures (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Capital Expenditures for 16 consecutive years, with $14000.0 as the latest value for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 111.48% year-over-year to $14000.0; the TTM value through Dec 2025 reached $102000.0, down 61.8%, while the annual FY2025 figure was $102000.0, 61.8% down from the prior year.
  • Capital Expenditures hit $14000.0 in Q4 2025 for Sangamo Therapeutics, down from $64000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $18.2 million in Q3 2021 and bottomed at -$18.9 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $2.2 million, with a median of $347000.0 recorded in 2024.
  • Year-over-year, Capital Expenditures skyrocketed 893.73% in 2022 and then tumbled 677.78% in 2025.
  • Sangamo Therapeutics' Capital Expenditures stood at -$18.9 million in 2021, then skyrocketed by 139.58% to $7.5 million in 2022, then plummeted by 64.26% to $2.7 million in 2023, then crashed by 104.57% to -$122000.0 in 2024, then skyrocketed by 111.48% to $14000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $14000.0, $64000.0, and -$210000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.